<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39335598</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9059</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>12</Day></PubDate></JournalIssue><Title>Biomedicines</Title><ISOAbbreviation>Biomedicines</ISOAbbreviation></Journal><ArticleTitle>Polyunsaturated Fatty Acids as Potential Treatments for COVID-19-Induced Anosmia.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2085</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biomedicines12092085</ELocationID><Abstract><AbstractText>Some individuals with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) experience anosmia, or loss of smell. Although the prevalence of anosmia has decreased with the emergence of the Omicron variant, it remains a significant concern. This review examines the potential role of polyunsaturated fatty acids (PUFAs), particularly omega-3 PUFAs, in treating COVID-19-induced anosmia by focusing on the underlying mechanisms of the condition. Omega-3 PUFAs are known for their anti-inflammatory, neuroprotective, and neurotransmission-enhancing properties, which could potentially aid in olfactory recovery. However, study findings are inconsistent. For instance, a placebo-controlled randomized clinical trial found no significant effect of omega-3 PUFA supplementation on olfactory recovery in patients with COVID-19-induced anosmia. These mixed results highlight the limitations of existing research, including small sample sizes, lack of placebo controls, short follow-up periods, and combined treatments. Therefore, more rigorous, large-scale studies are urgently needed to definitively assess the therapeutic potential of omega-3 PUFAs for olfactory dysfunction. Further research is also crucial to explore the broader role of PUFAs in managing viral infections and promoting sensory recovery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yu-Han</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Department of Education, National Taiwan University Hospital, Taipei 100, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chung-Wei</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Department of Education, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Otolaryngology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Chiung-Wei</ForeName><Initials>CW</Initials><Identifier Source="ORCID">0000-0001-8276-4538</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Kaohsiung Medical University, Kaohsiung 807, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Post-Baccalaureate Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NSTC 112-2320-B-037-010-MY3</GrantID><Agency>National Science and Technology Council</Agency><Country /></Grant><Grant><GrantID>KMU-M112004</GrantID><Agency>Kaohsiung Medical University</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomedicines</MedlineTA><NlmUniqueID>101691304</NlmUniqueID><ISSNLinking>2227-9059</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19-induced anosmia</Keyword><Keyword MajorTopicYN="N">omega-3 PUFAs</Keyword><Keyword MajorTopicYN="N">omega-6 PUFAs</Keyword><Keyword MajorTopicYN="N">polyunsaturated fatty acids</Keyword></KeywordList><CoiStatement>The authors declare that no conflicts of interest would prejudice the impartiality of this scientific work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39335598</ArticleId><ArticleId IdType="pmc">PMC11428228</ArticleId><ArticleId IdType="doi">10.3390/biomedicines12092085</ArticleId><ArticleId IdType="pii">biomedicines12092085</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yesudhas D., Srivastava A., Gromiha M.M. COVID-19 outbreak: History, mechanism, transmission, structural studies and therapeutics. Infection. 2021;49:199–213. doi: 10.1007/s15010-020-01516-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-020-01516-2</ArticleId><ArticleId IdType="pmc">PMC7472674</ArticleId><ArticleId IdType="pubmed">32886331</ArticleId></ArticleIdList></Reference><Reference><Citation>Scialo F., Daniele A., Amato F., Pastore L., Matera M.G., Cazzola M., Castaldo G., Bianco A. ACE2: The Major Cell Entry Receptor for SARS-CoV-2. Lung. 2020;198:867–877. doi: 10.1007/s00408-020-00408-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-020-00408-4</ArticleId><ArticleId IdType="pmc">PMC7653219</ArticleId><ArticleId IdType="pubmed">33170317</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilinska K., Jakubowska P., Von Bartheld C.S., Butowt R. Expression of the SARS-CoV-2 Entry Proteins, ACE2 and TMPRSS2, in Cells of the Olfactory Epithelium: Identification of Cell Types and Trends with Age. ACS Chem. Neurosci. 2020;11:1555–1562. doi: 10.1021/acschemneuro.0c00210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00210</ArticleId><ArticleId IdType="pmc">PMC7241737</ArticleId><ArticleId IdType="pubmed">32379417</ArticleId></ArticleIdList></Reference><Reference><Citation>Boechat J.L., Chora I., Morais A., Delgado L. The immune response to SARS-CoV-2 and COVID-19 immunopathology-Current perspectives. Pulmonology. 2021;27:423–437. doi: 10.1016/j.pulmoe.2021.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pulmoe.2021.03.008</ArticleId><ArticleId IdType="pmc">PMC8040543</ArticleId><ArticleId IdType="pubmed">33867315</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Connell P., Aldhamen Y.A. Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses. Hum. Vaccines Immunother. 2020;16:2980–2991. doi: 10.1080/21645515.2020.1802974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2020.1802974</ArticleId><ArticleId IdType="pmc">PMC8641610</ArticleId><ArticleId IdType="pubmed">32878546</ArticleId></ArticleIdList></Reference><Reference><Citation>Parasher A. COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment. Postgrad. Med. J. 2021;97:312–320. doi: 10.1136/postgradmedj-2020-138577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/postgradmedj-2020-138577</ArticleId><ArticleId IdType="pmc">PMC10017004</ArticleId><ArticleId IdType="pubmed">32978337</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgado A.M., Bezerra A., Felix E.B.G., Júnior J.C.S., Pinto N.B., Neto M.L.R., de Aguiar Rocha Martin A.L. COVID-19’s Clinical-Pathological Evidence in Relation to Its Repercussion on the Central and Peripheral Nervous System. Adv. Exp. Med. Biol. 2021;1353:197–215. doi: 10.1007/978-3-030-85113-2_11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-85113-2_11</ArticleId><ArticleId IdType="pubmed">35137375</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong J.Y., Wong A., Zhu D., Fastenberg J.H., Tham T., Surgery N. The prevalence of olfactory and gustatory dysfunction in COVID-19 patients: A systematic review and meta-analysis. Otolaryngol. Head. Neck Surg. 2020;163:3–11. doi: 10.1177/0194599820926473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0194599820926473</ArticleId><ArticleId IdType="pubmed">32369429</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P., Guida F., Polesel J., Marcuzzo A.V., Antonucci P., Capriotti V., Sacchet E., Cragnolini F., D’Alessandro A., Zanelli E., et al. Self-reported smell and taste recovery in coronavirus disease 2019 patients: A one-year prospective study. Eur Arch Otorhinolaryngol. 2022;279:515–520. doi: 10.1007/s00405-021-06839-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-021-06839-w</ArticleId><ArticleId IdType="pmc">PMC8103884</ArticleId><ArticleId IdType="pubmed">33963433</ArticleId></ArticleIdList></Reference><Reference><Citation>Doty R.L. Olfactory dysfunction in COVID-19: Pathology and long-term implications for brain health. Trends Mol. Med. 2022;28:781–794. doi: 10.1016/j.molmed.2022.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2022.06.005</ArticleId><ArticleId IdType="pmc">PMC9212891</ArticleId><ArticleId IdType="pubmed">35810128</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira L.A., Hopkins C., Petrocelli M., Lechien J.R., Cutrupi S., Salzano G., Chiesa-Estomba C.M., Saussez S., De Riu G. Efficacy of corticosteroid therapy in the treatment of long- lasting olfactory disorders in COVID-19 patients. Rhinology. 2021;59:21–25. doi: 10.4193/Rhin20.515.</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhin20.515</ArticleId><ArticleId IdType="pubmed">33290446</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Bartheld C.S., Wang L. Prevalence of Olfactory Dysfunction with the Omicron Variant of SARS-CoV-2: A Systematic Review and Meta-Analysis. Cells. 2023;12:430. doi: 10.3390/cells12030430.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12030430</ArticleId><ArticleId IdType="pmc">PMC9913864</ArticleId><ArticleId IdType="pubmed">36766771</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto J.M. Olfaction. Proc. Am. Thorac. Soc. 2011;8:46–52. doi: 10.1513/pats.201005-035RN.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/pats.201005-035RN</ArticleId><ArticleId IdType="pmc">PMC3131780</ArticleId><ArticleId IdType="pubmed">21364221</ArticleId></ArticleIdList></Reference><Reference><Citation>Bratman G.N., Bembibre C., Daily G.C., Doty R.L., Hummel T., Jacobs L.F., Kahn P.H., Lashus C., Majid A., Miller J.D., et al. Nature and human well-being: The olfactory pathway. Sci. Adv. 2024;10:eadn3028. doi: 10.1126/sciadv.adn3028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.adn3028</ArticleId><ArticleId IdType="pubmed">38748806</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarafoleanu C., Mella C., Georgescu M., Perederco C. The importance of the olfactory sense in the human behavior and evolution. J. Med. Life. 2009;2:196–198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3018978</ArticleId><ArticleId IdType="pubmed">20108540</ArticleId></ArticleIdList></Reference><Reference><Citation>Boesveldt S., Parma V. The importance of the olfactory system in human well-being, through nutrition and social behavior. Cell Tissue Res. 2021;383:559–567. doi: 10.1007/s00441-020-03367-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-020-03367-7</ArticleId><ArticleId IdType="pmc">PMC7802608</ArticleId><ArticleId IdType="pubmed">33433688</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel R.M., Pinto J.M. Olfaction: Anatomy, physiology, and disease. Clin. Anat. 2014;27:54–60. doi: 10.1002/ca.22338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ca.22338</ArticleId><ArticleId IdType="pubmed">24272785</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith T.D., Bhatnagar K.P. Anatomy of the olfactory system. Handb. Clin. Neurol. 2019;164:17–28. doi: 10.1016/B978-0-444-63855-7.00002-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-63855-7.00002-2</ArticleId><ArticleId IdType="pubmed">31604545</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos D.V., Reiter E.R., DiNardo L.J., Costanzo R.M. Hazardous Events Associated With Impaired Olfactory Function. Arch. Otolaryngol. Head. Neck Surg. 2004;130:317–319. doi: 10.1001/archotol.130.3.317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archotol.130.3.317</ArticleId><ArticleId IdType="pubmed">15023839</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo H.-S., Pramudya R.C., Singh A., Hummel T. Recent evidence for the impacts of olfactory disorders on food enjoyment and ingestive behavior. Curr. Opin. Food Sci. 2021;42:187–194. doi: 10.1016/j.cofs.2021.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cofs.2021.06.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevenson R.J. An initial evaluation of the functions of human olfaction. Chem. Senses. 2010;35:3–20. doi: 10.1093/chemse/bjp083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/chemse/bjp083</ArticleId><ArticleId IdType="pubmed">19942579</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkholi S.M.A., Abdelwahab M.K., Abdelhafeez M. Impact of the smell loss on the quality of life and adopted coping strategies in COVID-19 patients. Eur. Arch. Otorhinolaryngol. 2021;278:3307–3314. doi: 10.1007/s00405-020-06575-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-06575-7</ArticleId><ArticleId IdType="pmc">PMC7814376</ArticleId><ArticleId IdType="pubmed">33464401</ArticleId></ArticleIdList></Reference><Reference><Citation>Hummel T., Nordin S. Olfactory disorders and their consequences for quality of life. Acta Otolaryngol. 2005;125:116–121. doi: 10.1080/00016480410022787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00016480410022787</ArticleId><ArticleId IdType="pubmed">15880938</ArticleId></ArticleIdList></Reference><Reference><Citation>Pusswald G., Auff E., Lehrner J.J.C.P. Development of a brief self-report inventory to measure olfactory dysfunction and quality of life in patients with problems with the sense of smell. Chemosens. Percept. 2012;5:292–299. doi: 10.1007/s12078-012-9127-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12078-012-9127-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyama N., Kurihara K. Effect of odorants on lipid monolayers from bovine olfactory epithelium. Nature. 1972;236:402–404. doi: 10.1038/236402a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/236402a0</ArticleId><ArticleId IdType="pubmed">4553545</ArticleId></ArticleIdList></Reference><Reference><Citation>Calder P.C. Polyunsaturated fatty acids, inflammation, and immunity. Lipids. 2001;36:1007–1024. doi: 10.1007/s11745-001-0812-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11745-001-0812-7</ArticleId><ArticleId IdType="pubmed">11724453</ArticleId></ArticleIdList></Reference><Reference><Citation>Calder P.C. Polyunsaturated fatty acids and inflammation. Biochem. Soc. Trans. 2005;33:423–427. doi: 10.1042/BST0330423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST0330423</ArticleId><ArticleId IdType="pubmed">15787620</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantwell M.M. Assessment of individual fatty acid intake. Proc. Nutr. Soc. 2000;59:187–191. doi: 10.1017/S0029665100000203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0029665100000203</ArticleId><ArticleId IdType="pubmed">10946786</ArticleId></ArticleIdList></Reference><Reference><Citation>Calder P. Functional roles of fatty acids and their effects on human health. J. Parenter. Enter. Nutr. 2015;39:18S–32S. doi: 10.1177/0148607115595980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0148607115595980</ArticleId><ArticleId IdType="pubmed">26177664</ArticleId></ArticleIdList></Reference><Reference><Citation>Innis S.M. Fatty acids and early human development. Early Hum. Dev. 2007;83:761–766. doi: 10.1016/j.earlhumdev.2007.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.earlhumdev.2007.09.004</ArticleId><ArticleId IdType="pubmed">17920214</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapiero H., Ba G.N., Couvreur P., Tew K.D. Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies. Biomed. Pharmacother. 2002;56:215–222. doi: 10.1016/S0753-3322(02)00193-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0753-3322(02)00193-2</ArticleId><ArticleId IdType="pubmed">12199620</ArticleId></ArticleIdList></Reference><Reference><Citation>Harwood J.L. Polyunsaturated Fatty Acids: Conversion to Lipid Mediators, Roles in Inflammatory Diseases and Dietary Sources. Int. J. Mol. Sci. 2023;24:8838. doi: 10.3390/ijms24108838.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24108838</ArticleId><ArticleId IdType="pmc">PMC10218335</ArticleId><ArticleId IdType="pubmed">37240183</ArticleId></ArticleIdList></Reference><Reference><Citation>Innis S.M. Perinatal biochemistry and physiology of long-chain polyunsaturated fatty acids. J. Pediatr. 2003;143:1–8. doi: 10.1067/S0022-3476(03)00396-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/S0022-3476(03)00396-2</ArticleId><ArticleId IdType="pubmed">14597908</ArticleId></ArticleIdList></Reference><Reference><Citation>Eldsouky S.M., Kazem N.G., Shahat A.K., Ragab R.N., El-Sayed M.S., Abdelmotaleb D.S., Mohammed L.A., Mohamed S.A., Elsayed E. Vitamin D and Omega-3 long chain polyunsaturated fatty acids lowering COVID-19 cytokines and anosmia. Egypt. J. Hosp. Med. 2023;93:7567–7574. doi: 10.21608/ejhm.2023.327573.</Citation><ArticleIdList><ArticleId IdType="doi">10.21608/ejhm.2023.327573</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez A.K., Woosch D., Haehner A., Hummel T. Omega-3 supplementation in postviral olfactory dysfunction: A pilot study. Rhinology. 2022;60:139–144. doi: 10.4193/Rhin21.378.</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhin21.378</ArticleId><ArticleId IdType="pubmed">35112672</ArticleId></ArticleIdList></Reference><Reference><Citation>Denis I., Potier B., Heberden C., Vancassel S. Omega-3 polyunsaturated fatty acids and brain aging. Curr. Opin. Clin. Nutr. Metab. Care. 2015;18:139–146. doi: 10.1097/MCO.0000000000000141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCO.0000000000000141</ArticleId><ArticleId IdType="pubmed">25501348</ArticleId></ArticleIdList></Reference><Reference><Citation>Marza E., Lesa G.M. Polyunsaturated fatty acids and neurotransmission in Caenorhabditis elegans. Biochem. Soc. Trans. 2006;34:77–80. doi: 10.1042/BST0340077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST0340077</ArticleId><ArticleId IdType="pubmed">16417487</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn-Kirby A.H., Dantzker J.L., Apicella A.J., Schafer W.R., Browse J., Bargmann C.I., Watts J.L. Specific polyunsaturated fatty acids drive TRPV-dependent sensory signaling in vivo. Cell. 2004;119:889–900. doi: 10.1016/j.cell.2004.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2004.11.005</ArticleId><ArticleId IdType="pubmed">15607983</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Halloran D.M., Altshuler-Keylin S., Lee J.I., L’Etoile N.D. Regulators of AWC-mediated olfactory plasticity in Caenorhabditis elegans. PLoS Genet. 2009;5:e1000761. doi: 10.1371/journal.pgen.1000761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1000761</ArticleId><ArticleId IdType="pmc">PMC2780698</ArticleId><ArticleId IdType="pubmed">20011101</ArticleId></ArticleIdList></Reference><Reference><Citation>Lessard-Beaudoin M., M. Gonzalez L., AlOtaibi M., Chouinard-Watkins R., Plourde M., Calon F., Graham R.K. Diet enriched in omega-3 fatty acids alleviates olfactory system deficits in APOE4 transgenic mice. Eur. J. Neurosci. 2021;54:7092–7108. doi: 10.1111/ejn.15472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejn.15472</ArticleId><ArticleId IdType="pubmed">34549475</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerner D.K., Garvey K.L., Arrighi-Allisan A., Kominsky E., Filimonov A., Al-Awady A., Filip P., Liu K., Ninan S., Spock T., et al. Omega-3 Fatty Acid Supplementation for the Treatment of Persistent COVID-Related Olfactory Dysfunction. Am. J. Rhinol. Allergy. 2023;37:531–540. doi: 10.1177/19458924231174799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/19458924231174799</ArticleId><ArticleId IdType="pubmed">37261995</ArticleId></ArticleIdList></Reference><Reference><Citation>Ottaiano A.C., Freddi T.d.A.L., Lucio L.L. The Olfactory Nerve: Anatomy and Pathology. Semin. Ultrasound CT MRI. 2022;43:371–377. doi: 10.1053/j.sult.2022.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.sult.2022.04.001</ArticleId><ArticleId IdType="pubmed">36116849</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A., Kumar R., Aier I., Semwal R., Tyagi P., Varadwaj P. Sense of Smell: Structural, Functional, Mechanistic Advancements and Challenges in Human Olfactory Research. Curr. Neuropharmacol. 2019;17:891–911. doi: 10.2174/1570159X17666181206095626.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570159X17666181206095626</ArticleId><ArticleId IdType="pmc">PMC7052838</ArticleId><ArticleId IdType="pubmed">30520376</ArticleId></ArticleIdList></Reference><Reference><Citation>Huynh P.P., Ishii L.E., Ishii M. What is anosmia? JAMA. 2020;324:206. doi: 10.1001/jama.2020.10966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.10966</ArticleId><ArticleId IdType="pubmed">32556300</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Lui F. Anosmia. Volume 3. StatPearls; St. Petersburg, FL, USA: 2024. pp. 1–4.</Citation></Reference><Reference><Citation>Gaines A.D. Anosmia and hyposmia. Allergy Asthma Proc. 2010;31:185–189. doi: 10.2500/aap.2010.31.3357.</Citation><ArticleIdList><ArticleId IdType="doi">10.2500/aap.2010.31.3357</ArticleId><ArticleId IdType="pubmed">20615320</ArticleId></ArticleIdList></Reference><Reference><Citation>Soudry Y., Lemogne C., Malinvaud D., Consoli S.M., Bonfils P. Olfactory system and emotion: Common substrates. Eur. Ann. Otorhinolaryngol. Head. Neck Dis. 2011;128:18–23. doi: 10.1016/j.anorl.2010.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anorl.2010.09.007</ArticleId><ArticleId IdType="pubmed">21227767</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y., Min P., Lee S., Kim S.W. Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients. J. Korean Med. Sci. 2020;35:e174. doi: 10.3346/jkms.2020.35.e174.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2020.35.e174</ArticleId><ArticleId IdType="pmc">PMC7211515</ArticleId><ArticleId IdType="pubmed">32383370</ArticleId></ArticleIdList></Reference><Reference><Citation>Butowt R., Bilinska K., von Bartheld C.S. Olfactory dysfunction in COVID-19: New insights into the underlying mechanisms. Trends Neurosci. 2023;46:75–90. doi: 10.1016/j.tins.2022.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2022.11.003</ArticleId><ArticleId IdType="pmc">PMC9666374</ArticleId><ArticleId IdType="pubmed">36470705</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos R.E.A., da Silva M.G., do Monte Silva M.C.B., Barbosa D.A.M., Gomes A., Galindo L.C.M., da Silva Aragão R., Ferraz-Pereira K.N. Onset and duration of symptoms of loss of smell/taste in patients with COVID-19: A systematic review. Am. J. Otolaryngol. 2021;42:102889. doi: 10.1016/j.amjoto.2020.102889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjoto.2020.102889</ArticleId><ArticleId IdType="pmc">PMC7833280</ArticleId><ArticleId IdType="pubmed">33445036</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Chiesa-Estomba C.M., De Siati D.R., Horoi M., Le Bon S.D., Rodriguez A., Dequanter D., Blecic S., El Afia F., Distinguin L.J.E.A. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): A multicenter European study. Eur. Arch. Oto-Rhino-Laryngol. 2020;277:2251–2261. doi: 10.1007/s00405-020-05965-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-05965-1</ArticleId><ArticleId IdType="pmc">PMC7134551</ArticleId><ArticleId IdType="pubmed">32253535</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsukahara T., Brann D.H., Datta S.R. Mechanisms of SARS-CoV-2-associated anosmia. Physiol. Rev. 2023;103:2759–2766. doi: 10.1152/physrev.00012.2023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00012.2023</ArticleId><ArticleId IdType="pmc">PMC10625840</ArticleId><ArticleId IdType="pubmed">37342077</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira L.A., Salzano G., Fois A.G., Piombino P., De Riu G. Potential pathogenesis of ageusia and anosmia in COVID-19 patients. Int. Forum Allergy Rhinol. 2020;10:1103–1104. doi: 10.1002/alr.22593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22593</ArticleId><ArticleId IdType="pmc">PMC7267531</ArticleId><ArticleId IdType="pubmed">32342636</ArticleId></ArticleIdList></Reference><Reference><Citation>Brann D.H., Tsukahara T., Weinreb C., Lipovsek M., Van den Berge K., Gong B., Chance R., Macaulay I.C., Chou H.-J., Fletcher R.B., et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci. Adv. 2020;6:5801–5820. doi: 10.1126/sciadv.abc5801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abc5801</ArticleId><ArticleId IdType="pmc">PMC10715684</ArticleId><ArticleId IdType="pubmed">32937591</ArticleId></ArticleIdList></Reference><Reference><Citation>Butowt R., Bilińska K., von Bartheld C. Why Does the Omicron Variant Largely Spare Olfactory Function? Implications for the Pathogenesis of Anosmia in Coronavirus Disease 2019. J. Infect. Dis. 2022;226:1304–1308. doi: 10.1093/infdis/jiac113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac113</ArticleId><ArticleId IdType="pmc">PMC9129133</ArticleId><ArticleId IdType="pubmed">35467743</ArticleId></ArticleIdList></Reference><Reference><Citation>Keshavarz P., Haseli S., Yazdanpanah F., Bagheri F., Raygani N., Karimi-Galougahi M. A Systematic Review of Imaging Studies in Olfactory Dysfunction Secondary to COVID-19. Acad. Radiol. 2021;28:1530–1540. doi: 10.1016/j.acra.2021.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acra.2021.08.010</ArticleId><ArticleId IdType="pmc">PMC8403662</ArticleId><ArticleId IdType="pubmed">34548231</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Bon S.D., Horoi M. Is anosmia the price to pay in an immune-induced scorched-earth policy against COVID-19? Med. Hypotheses. 2020;143:109881. doi: 10.1016/j.mehy.2020.109881.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.109881</ArticleId><ArticleId IdType="pmc">PMC7248625</ArticleId><ArticleId IdType="pubmed">32474381</ArticleId></ArticleIdList></Reference><Reference><Citation>Torabi A., Mohammadbagheri E., Akbari Dilmaghani N., Bayat A.-H., Fathi M., Vakili K., Alizadeh R., Rezaeimirghaed O., Hajiesmaeili M., Ramezani M.J.A. Proinflammatory cytokines in the olfactory mucosa result in COVID-19 induced anosmia. ACS Chem. Neurosci. 2020;11:1909–1913. doi: 10.1021/acschemneuro.0c00249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00249</ArticleId><ArticleId IdType="pubmed">32525657</ArticleId></ArticleIdList></Reference><Reference><Citation>Finlay J.B., Brann D.H., Abi Hachem R., Jang D.W., Oliva A.D., Ko T., Gupta R., Wellford S.A., Moseman E.A., Jang S.S., et al. Persistent post-COVID-19 smell loss is associated with immune cell infiltration and altered gene expression in olfactory epithelium. Sci. Transl. Med. 2022;14:eadd0484. doi: 10.1126/scitranslmed.add0484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.add0484</ArticleId><ArticleId IdType="pmc">PMC10317309</ArticleId><ArticleId IdType="pubmed">36542694</ArticleId></ArticleIdList></Reference><Reference><Citation>de Melo G.D., Lazarini F., Levallois S., Hautefort C., Michel V., Larrous F., Verillaud B., Aparicio C., Wagner S., Gheusi G., et al. COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci. Transl. Med. 2021;13:596. doi: 10.1126/scitranslmed.abf8396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abf8396</ArticleId><ArticleId IdType="pmc">PMC8158965</ArticleId><ArticleId IdType="pubmed">33941622</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakatani H., Kono M., Shiga T., Kuwazoe H., Nanushaj D., Matsuzaki I., Murata S.-I., Miyajima M., Okada Y., Saika H.M., et al. The Roles of transient receptor potential vanilloid 1 and 4 in olfactory regeneration. Lab. Investig. 2023;103:100051. doi: 10.1016/j.labinv.2022.100051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.labinv.2022.100051</ArticleId><ArticleId IdType="pubmed">36870285</ArticleId></ArticleIdList></Reference><Reference><Citation>Liviero F., Campisi M., Mason P., Pavanello S. Transient Receptor Potential Vanilloid Subtype 1: Potential Role in Infection, Susceptibility, Symptoms and Treatment of COVID-19. Front. Med. 2021;8:753819. doi: 10.3389/fmed.2021.753819.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.753819</ArticleId><ArticleId IdType="pmc">PMC8599155</ArticleId><ArticleId IdType="pubmed">34805220</ArticleId></ArticleIdList></Reference><Reference><Citation>Maaroufi H. Interactions of SARS-CoV-2 spike protein and transient receptor potential (TRP) cation channels could explain smell, taste, and/or chemesthesis disorders. arXiv. 2021 doi: 10.48550/arXiv.2101.06294.2101.06294</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.2101.06294</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M., Ma Y., Ye X., Zhang N., Pan L., Wang B. TRP (transient receptor potential) ion channel family: Structures, biological functions and therapeutic interventions for diseases. Signal Transduct. Target. Ther. 2023;8:261. doi: 10.1038/s41392-023-01464-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-023-01464-x</ArticleId><ArticleId IdType="pmc">PMC10319900</ArticleId><ArticleId IdType="pubmed">37402746</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung M.-K., Jung S.J., Oh S.B. Role of TRP Channels in Pain Sensation. In: Islam M.S., editor. Transient Receptor Potential Channels. Springer; Dordrecht, The Netherlands: 2011. pp. 615–636.</Citation><ArticleIdList><ArticleId IdType="pubmed">21290319</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman H.A., Chen A., Kravatz N.L., Chavan S.S., Chang E.H. Involvement of Neural Transient Receptor Potential Channels in Peripheral Inflammation. Front. Immunol. 2020;11:590261. doi: 10.3389/fimmu.2020.590261.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.590261</ArticleId><ArticleId IdType="pmc">PMC7645044</ArticleId><ArticleId IdType="pubmed">33193423</ArticleId></ArticleIdList></Reference><Reference><Citation>Liedtke W.B., Heller S., editors. TRP Ion Channel Function in Sensory Transduction and Cellular Signaling Cascades. 1st ed. CRC Press; Boca Raton, FL, USA: 2007. pp. 213–242.</Citation><ArticleIdList><ArticleId IdType="pubmed">21204486</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakashimo Y., Takumida M., Fukuiri T., Anniko M., Hirakawa K. Expression of transient receptor potential channel vanilloid (TRPV) 1–4, melastin (TRPM) 5 and 8, and ankyrin (TRPA1) in the normal and methimazole-treated mouse olfactory epithelium. Acta Oto-Laryngol. 2010;130:1278–1286. doi: 10.3109/00016489.2010.489573.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00016489.2010.489573</ArticleId><ArticleId IdType="pmc">PMC2981077</ArticleId><ArticleId IdType="pubmed">20586674</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueda T., Hoshikawa M., Shibata Y., Kumamoto N., Ugawa S. Basal cells express functional TRPV4 channels in the mouse nasal epithelium. Biochem. Biophys. Rep. 2015;4:169–174. doi: 10.1016/j.bbrep.2015.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrep.2015.09.008</ArticleId><ArticleId IdType="pmc">PMC5668914</ArticleId><ArticleId IdType="pubmed">29124201</ArticleId></ArticleIdList></Reference><Reference><Citation>Okada Y., Shirai K., Miyajima M., Reinach P.S., Yamanaka O., Sumioka T., Kokado M., Tomoyose K., Saika S. Loss of TRPV4 Function Suppresses Inflammatory Fibrosis Induced by Alkali-Burning Mouse Corneas. PLoS ONE. 2016;11:e0167200. doi: 10.1371/journal.pone.0167200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0167200</ArticleId><ArticleId IdType="pmc">PMC5193391</ArticleId><ArticleId IdType="pubmed">28030558</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Saigh N.N., Harb A.A., Abdalla S. Receptors Involved in COVID-19-Related Anosmia: An Update on the Pathophysiology and the Mechanistic Aspects. Int. J. Mol. Sci. 2024;25:8527. doi: 10.3390/ijms25158527.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms25158527</ArticleId><ArticleId IdType="pmc">PMC11313362</ArticleId><ArticleId IdType="pubmed">39126095</ArticleId></ArticleIdList></Reference><Reference><Citation>Najafloo R., Majidi J., Asghari A., Aleemardani M., Kamrava S.K., Simorgh S., Seifalian A., Bagher Z., Seifalian A.M. Mechanism of Anosmia Caused by Symptoms of COVID-19 and Emerging Treatments. ACS Chem. Neurosci. 2021;12:3795–3805. doi: 10.1021/acschemneuro.1c00477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.1c00477</ArticleId><ArticleId IdType="pubmed">34609841</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng X., Pan Y. COVID-19 and anosmia: The story so far. Ear Nose Throat J. 2021;103:NP312–NP320. doi: 10.1177/01455613211048998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01455613211048998</ArticleId><ArticleId IdType="pubmed">34587819</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilinska K., Butowt R. Anosmia in COVID-19: A Bumpy Road to Establishing a Cellular Mechanism. ACS Chem. Neurosci. 2020;11:2152–2155. doi: 10.1021/acschemneuro.0c00406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00406</ArticleId><ArticleId IdType="pmc">PMC7467568</ArticleId><ArticleId IdType="pubmed">32673476</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhutani D.L., Ross A.G., Lehman A.Y., Shindler K.S. Resolution of COVID-19 induced anosmia following treatment with ST266. Otolaryngol. Case Rep. 2022;25:100475. doi: 10.1016/j.xocr.2022.100475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xocr.2022.100475</ArticleId><ArticleId IdType="pmc">PMC9444303</ArticleId><ArticleId IdType="pubmed">36090590</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamad S.A., Badawi A.M., Mansour H.F. Insulin fast-dissolving film for intranasal delivery via olfactory region, a promising approach for the treatment of anosmia in COVID-19 patients: Design, in-vitro characterization and clinical evaluation. Int. J. Pharm. 2021;601:120600. doi: 10.1016/j.ijpharm.2021.120600.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijpharm.2021.120600</ArticleId><ArticleId IdType="pubmed">33862126</ArticleId></ArticleIdList></Reference><Reference><Citation>Husain P., Ahmed S.K., Husain B. Role of Doxycycline, Oral Steroids, and Nasal Steroid in Treatment of Anosmia Due to COVID-19 with the New Insights into the Doxycycline Activity. Department of ENT, Expert ENT &amp; Diagnostic Centre; Barabanki, India: 2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-107710/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Riccardi G., Niccolini G.F., Bellizzi M.G., Fiore M., Minni A., Barbato C. Post-COVID-19 Anosmia and Therapies: Stay Tuned for New Drugs to Sniff Out. Disease. 2023;11:79. doi: 10.3390/diseases11020079.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diseases11020079</ArticleId><ArticleId IdType="pmc">PMC10297121</ArticleId><ArticleId IdType="pubmed">37366867</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo B.T., Marik P., Kory P., Shapiro L., Thomadsen R., Iglesias J., Ditmore S., Rendell M., Varon J., Dubé M., et al. The time to offer treatments for COVID-19. Expert. Opin. Investig. Drugs. 2021;30:505–518. doi: 10.1080/13543784.2021.1901883.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13543784.2021.1901883</ArticleId><ArticleId IdType="pmc">PMC8074648</ArticleId><ArticleId IdType="pubmed">33721548</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkazzaz M., Haydara T., Abo-Amer Y., Sahyon H., Shamkh I.M., Ahmed A. STRA6, as a novel binding receptor of COVID-19, a breakthrough that could explain COVID-19 symptoms with unknown aetiology. Res. Sq. 2021;27:1–32. doi: 10.21203/rs.3.rs-936697/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-936697/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Swain S.K., Pani S.R. Role of oral corticosteroid and olfactory training for treatment of Post-COVID-19 olfactory dysfunction: Our experiences. Apollo Med. 2021;18:162–165. doi: 10.4103/am.am_61_21.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/am.am_61_21</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Journe F., Hans S., Chiesa-Estomba C.M., Mustin V., Beckers E., Vaira L.A., De Riu G., Hopkins C., Saussez S. Severity of anosmia as an early symptom of COVID-19 infection may predict lasting loss of smell. Front. Med. 2020;7:582802. doi: 10.3389/fmed.2020.582802.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.582802</ArticleId><ArticleId IdType="pmc">PMC7732577</ArticleId><ArticleId IdType="pubmed">33330539</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinidis I., Tsakiropoulou E., Constantinidis J. Long term effects of olfactory training in patients with post-infectious olfactory loss. Rhinology. 2016;54:170–175. doi: 10.4193/Rhino15.264.</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhino15.264</ArticleId><ArticleId IdType="pubmed">27017331</ArticleId></ArticleIdList></Reference><Reference><Citation>Damm M., Pikart L.K., Reimann H., Burkert S., Göktas Ö., Haxel B., Frey S., Charalampakis I., Beule A., Renner B., et al. Olfactory training is helpful in postinfectious olfactory loss: A randomized, controlled, multicenter study. Laryngoscope. 2014;124:826–831. doi: 10.1002/lary.24340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.24340</ArticleId><ArticleId IdType="pubmed">23929687</ArticleId></ArticleIdList></Reference><Reference><Citation>Hummel T., Rissom K., Reden J., Hähner A., Weidenbecher M., Hüttenbrink K.B. Effects of olfactory training in patients with olfactory loss. Laryngoscope. 2009;119:496–499. doi: 10.1002/lary.20101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.20101</ArticleId><ArticleId IdType="pubmed">19235739</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinidis I., Tsakiropoulou E., Bekiaridou P., Kazantzidou C., Constantinidis J. Use of olfactory training in post-traumatic and postinfectious olfactory dysfunction. Laryngoscope. 2013;123:E85–E90. doi: 10.1002/lary.24390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.24390</ArticleId><ArticleId IdType="pubmed">24114690</ArticleId></ArticleIdList></Reference><Reference><Citation>Rashid R.A., Zgair A., Al-Ani R.M. Effect of nasal corticosteroid in the treatment of anosmia due to COVID-19: A randomised double-blind placebo-controlled study. Am. J. Otolaryngol. 2021;42:103033. doi: 10.1016/j.amjoto.2021.103033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjoto.2021.103033</ArticleId><ArticleId IdType="pmc">PMC8024226</ArticleId><ArticleId IdType="pubmed">33839489</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu T.J., Yu A.C., Lee J.T. Management of post-COVID-19 olfactory dysfunction. Curr. Treat. Options Allergy. 2022;9:1–18. doi: 10.1007/s40521-021-00297-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40521-021-00297-9</ArticleId><ArticleId IdType="pmc">PMC8723803</ArticleId><ArticleId IdType="pubmed">35004126</ArticleId></ArticleIdList></Reference><Reference><Citation>Espehana A., Lee L., Garden E.M., Klyvyte G., Gokani S., Jegatheeswaran L., Wong J.J., Philpott C. Delivery of Topical Drugs to the Olfactory Cleft. J. Clin. Med. 2023;12:7387. doi: 10.3390/jcm12237387.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12237387</ArticleId><ArticleId IdType="pmc">PMC10707438</ArticleId><ArticleId IdType="pubmed">38068438</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitcroft K.L., Altundag A., Balungwe P., Boscolo-Rizzo P., Douglas R., Enecilla M.L.B., Fjaeldstad A.W., Fornazieri M.A., Frasnelli J., Gane S., et al. Position paper on olfactory dysfunction: 2023. Rhinology. 2023;61:1–108. doi: 10.4193/Rhin22.483.</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhin22.483</ArticleId><ArticleId IdType="pubmed">37454287</ArticleId></ArticleIdList></Reference><Reference><Citation>Thamboo A., Manji J., Szeitz A., Santos R.D., Hathorn I., Gan E.C., Alsaleh S., Javer A.R. The safety and efficacy of short-term budesonide delivered via mucosal atomization device for chronic rhinosinusitis without nasal polyposis. Int. Forum Allergy Rhinol. 2014;4:397–402. doi: 10.1002/alr.21280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.21280</ArticleId><ArticleId IdType="pubmed">24449682</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvey R.J., Snidvongs K., Kalish L.H., Oakley G.M., Sacks R. Corticosteroid nasal irrigations are more effective than simple sprays in a randomized double-blinded placebo-controlled trial for chronic rhinosinusitis after sinus surgery. Int. Forum Allergy Rhinol. 2018;8:461–470. doi: 10.1002/alr.22093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22093</ArticleId><ArticleId IdType="pubmed">29394004</ArticleId></ArticleIdList></Reference><Reference><Citation>Morita A., Murakami A., Uchihara T., Ohashi N., Ryu K., Watanabe Y., Ochi S., Okudaira K., Hirasaki Y., Namiki T. Case Report: Acupuncture is an effective treatment for olfactory dysfunction in the post COVID-19 condition. Front. Neurol. 2022;13:916944. doi: 10.3389/fneur.2022.916944.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.916944</ArticleId><ArticleId IdType="pmc">PMC9445155</ArticleId><ArticleId IdType="pubmed">36081871</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy-Chowdhury S., Satishkumar A., Ahmed S., Mardon A.A. Dietary Approach for Post-COVID Treatment of Olfactory Loss. Integr. J. Med. Sci. 2021;8:1–4. doi: 10.15342/ijms.2021.439.</Citation><ArticleIdList><ArticleId IdType="doi">10.15342/ijms.2021.439</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamady A.A., Mikhail B., El desoky M., Abu Shady E.F. Therapeutic effect of combined oral Vitamin A and corticosteroid nasal spray in recovery of smell sensation in COVID_19 Patients. Egypt. J. Ear Nose Throat Allied Sci. 2024;25:1–6. doi: 10.21608/ejentas.2024.251053.1690.</Citation><ArticleIdList><ArticleId IdType="doi">10.21608/ejentas.2024.251053.1690</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan R.S., Dine K., Bauman B., Lorentsen M., Lin L., Brown H., Hanson L.R., Svitak A.L., Wessel H., Brown L., et al. Intranasal Delivery of A Novel Amnion Cell Secretome Prevents Neuronal Damage and Preserves Function In A Mouse Multiple Sclerosis Model. Sci. Rep. 2017;7:41768. doi: 10.1038/srep41768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep41768</ArticleId><ArticleId IdType="pmc">PMC5282572</ArticleId><ArticleId IdType="pubmed">28139754</ArticleId></ArticleIdList></Reference><Reference><Citation>Grinblat G.A., Khan R.S., Dine K., Wessel H., Brown L., Shindler K.S. RGC Neuroprotection Following Optic Nerve Trauma Mediated By Intranasal Delivery of Amnion Cell Secretome. Investig. Ophthalmol. Vis. Sci. 2018;59:2470–2477. doi: 10.1167/iovs.18-24096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.18-24096</ArticleId><ArticleId IdType="pmc">PMC5959511</ArticleId><ArticleId IdType="pubmed">29847652</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniel D., Paula L.N., Eduardo B.M., Daniel G.A., Andrea D.E., Fernando L.N., Armando M.C. Intranasal insulin for COVID-19-related smell loss. Eur. Arch. Otorhinolaryngol. 2024;281:201–205. doi: 10.1007/s00405-023-08176-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-023-08176-6</ArticleId><ArticleId IdType="pubmed">37608216</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherobin G.B., Guimarães R.E.S., de Paula Gomes M.C., Vasconcelos L.O.G., de Abreu L.A.N. Intranasal Insulin for the Treatment of Persistent Post-COVID-19 Olfactory Dysfunction. Otolaryngol. Head. Neck Surg. Off. J. Am. Acad. Otolaryngol. Head. Neck Surg. 2023;169:719–724. doi: 10.1002/ohn.352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ohn.352</ArticleId><ArticleId IdType="pubmed">37078341</ArticleId></ArticleIdList></Reference><Reference><Citation>AlBilasi T.M., Alanazi R.M., AlDhawi L.F., Albathi A.A. Outcome and Safety of Insulin in the Management of Smell Loss: A Systematic Review. Ear Nose Throat J. 2023:1455613231201028. doi: 10.1177/01455613231201028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01455613231201028</ArticleId><ArticleId IdType="pubmed">37776014</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezaeian A. Effect of Intranasal Insulin on Olfactory Recovery in Patients with Hyposmia: A Randomized Clinical Trial. Otolaryngol. Head. Neck Surg. 2018;158:1134–1139. doi: 10.1177/0194599818764624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0194599818764624</ArticleId><ArticleId IdType="pubmed">29557250</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan C.H., Jang S.S., Lin H.C., Ma Y., Khanwalkar A.R., Thai A., Patel Z.M. Use of platelet-rich plasma for COVID-19-related olfactory loss: A randomized controlled trial. Int. Forum Allergy Rhinol. 2023;13:989–997. doi: 10.1002/alr.23116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.23116</ArticleId><ArticleId IdType="pmc">PMC9877663</ArticleId><ArticleId IdType="pubmed">36507615</ArticleId></ArticleIdList></Reference><Reference><Citation>Steffens Y., Le Bon S.D., Lechien J., Prunier L., Rodriguez A., Saussez S., Horoi M. Effectiveness and safety of PRP on persistent olfactory dysfunction related to COVID-19. Eur. Arch. Otorhinolaryngol. 2022;279:5951–5953. doi: 10.1007/s00405-022-07560-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-022-07560-y</ArticleId><ArticleId IdType="pmc">PMC9336533</ArticleId><ArticleId IdType="pubmed">35904632</ArticleId></ArticleIdList></Reference><Reference><Citation>Vityala Y., Zhumabaeva S., Imankulova B., Kurmanalieva A., Mamatov S.M. Use of B-complex vitamins and olfactory training for treating COVID-19-related anosmia. Clin. Case Rep. 2021;9:e05069. doi: 10.1002/ccr3.5069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccr3.5069</ArticleId><ArticleId IdType="pmc">PMC8590088</ArticleId><ArticleId IdType="pubmed">34804531</ArticleId></ArticleIdList></Reference><Reference><Citation>El Soury M., Fornasari B.E., Carta G., Zen F., Haastert-Talini K., Ronchi G. The Role of Dietary Nutrients in Peripheral Nerve Regeneration. Int. J. Mol. Sci. 2021;14:7417. doi: 10.3390/ijms22147417.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22147417</ArticleId><ArticleId IdType="pmc">PMC8303934</ArticleId><ArticleId IdType="pubmed">34299037</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimoto S., Tanaka H., Okamoto M., Okada K., Murase T., Yoshikawa H. Methylcobalamin promotes the differentiation of Schwann cells and remyelination in lysophosphatidylcholine-induced demyelination of the rat sciatic nerve. Front. Cell. Neurosci. 2015;9:298. doi: 10.3389/fncel.2015.00298.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00298</ArticleId><ArticleId IdType="pmc">PMC4523890</ArticleId><ArticleId IdType="pubmed">26300733</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Saaeed S., Ali H., Ali S., Ali S. Vitamins B therapy in regeneration of peripheral neuropathy associated with lipid profile. J. Phys. Conf. Ser. 2019;1279:012016. doi: 10.1088/1742-6596/1279/1/012016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1088/1742-6596/1279/1/012016</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Stadio A., Gallina S., Cocuzza S., De Luca P., Ingrassia A., Oliva S., Sireci F., Camaioni A., Ferreli F., Mercante G., et al. Treatment of COVID-19 olfactory dysfunction with olfactory training, palmitoylethanolamide with luteolin, or combined therapy: A blinded controlled multicenter randomized trial. Eur. Arch. Oto-Rhino-Laryngol. 2023;280:4949–4961. doi: 10.1007/s00405-023-08085-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-023-08085-8</ArticleId><ArticleId IdType="pmc">PMC10562315</ArticleId><ArticleId IdType="pubmed">37380908</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Stadio A., D’Ascanio L., Vaira L.A., Cantone E., De Luca P., Cingolani C., Motta G., De Riu G., Vitelli F., Spriano G., et al. Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combined with Olfactory Training to Treat Post-COVID-19 Olfactory Impairment: A Multi-Center Double-Blinded Randomized Placebo- Controlled Clinical Trial. Curr. Neuropharmacol. 2022;20:2001–2012. doi: 10.2174/1570159X20666220420113513.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570159X20666220420113513</ArticleId><ArticleId IdType="pmc">PMC9886808</ArticleId><ArticleId IdType="pubmed">35450527</ArticleId></ArticleIdList></Reference><Reference><Citation>D’Ascanio L., Vitelli F., Cingolani C., Maranzano M., Brenner M.J., Di Stadio A. Randomized clinical trial “olfactory dysfunction after COVID-19: Olfactory rehabilitation therapy vs. intervention treatment with Palmitoylethanolamide and Luteolin”: Preliminary results. Eur. Rev. Med. Pharmacol. Sci. 2021;25:4156–4162. doi: 10.26355/eurrev_202106_26059.</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202106_26059</ArticleId><ArticleId IdType="pubmed">34156697</ArticleId></ArticleIdList></Reference><Reference><Citation>De Luca P., Camaioni A., Marra P., Salzano G., Carriere G., Ricciardi L., Pucci R., Montemurro N., Brenner M.J., Di Stadio A. Effect of Ultra-Micronized Palmitoylethanolamide and Luteolin on Olfaction and Memory in Patients with Long COVID: Results of a Longitudinal Study. Cells. 2022;11:2552. doi: 10.3390/cells11162552.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11162552</ArticleId><ArticleId IdType="pmc">PMC9406356</ArticleId><ArticleId IdType="pubmed">36010630</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamed S.A., Ahmed M.A.A. The effectiveness of cerebrolysin, a multi-modal neurotrophic factor, for treatment of post-COVID-19 persistent olfactory, gustatory and trigeminal chemosensory dysfunctions: A randomized clinical trial. Expert. Rev. Clin. Pharmacol. 2023;16:1261–1276. doi: 10.1080/17512433.2023.2282715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17512433.2023.2282715</ArticleId><ArticleId IdType="pubmed">37950370</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkazzaz M., Abo-Amer Y.E.-E., Ahmed A., Haydara T. 13 cis retinoic acid improved the outcomes of COVID-19 patients. A randomized clinical trial. medRxiv. 2022;8:1–36. doi: 10.1101/2022.03.05.22271959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.03.05.22271959</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan B.K.J., Han R., Zhao J.J., Tan N.K.W., Quah E.S.H., Tan C.J.-W., Chan Y.H., Teo N.W.Y., Charn T.C., See A., et al. Prognosis and persistence of smell and taste dysfunction in patients with COVID-19: Meta-analysis with parametric cure modelling of recovery curves. BMJ. 2022;378:e069503. doi: 10.1136/bmj-2021-069503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069503</ArticleId><ArticleId IdType="pmc">PMC9326326</ArticleId><ArticleId IdType="pubmed">35896188</ArticleId></ArticleIdList></Reference><Reference><Citation>Goran M.I. Energy Metabolism and Obesity. Med. Clin. N. Am. 2000;84:347–362. doi: 10.1016/S0025-7125(05)70225-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0025-7125(05)70225-X</ArticleId><ArticleId IdType="pubmed">10793646</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao A.M., Quigley K.M., Wadden T.A. Dietary interventions for obesity: Clinical and mechanistic findings. J. Clin. Investig. 2021;131 doi: 10.1172/JCI140065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI140065</ArticleId><ArticleId IdType="pmc">PMC7773341</ArticleId><ArticleId IdType="pubmed">33393504</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolls B.J. Dietary energy density: Applying behavioural science to weight management. Nutr. Bull. 2017;42:246–253. doi: 10.1111/nbu.12280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nbu.12280</ArticleId><ArticleId IdType="pmc">PMC5687574</ArticleId><ArticleId IdType="pubmed">29151813</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno M.J., Martínez J.A. Adipose tissue: A storage and secretory organ. An. Del. Sist. Sanit. De Navar. 2002;25((Suppl. S1)):29–39. doi: 10.23938/assn.0812.</Citation><ArticleIdList><ArticleId IdType="doi">10.23938/assn.0812</ArticleId><ArticleId IdType="pubmed">12861268</ArticleId></ArticleIdList></Reference><Reference><Citation>Trayhurn P., Beattie J.H. Physiological role of adipose tissue: White adipose tissue as an endocrine and secretory organ. Proc. Nutr. Soc. 2001;60:329–339. doi: 10.1079/PNS200194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1079/PNS200194</ArticleId><ArticleId IdType="pubmed">11681807</ArticleId></ArticleIdList></Reference><Reference><Citation>Galic S., Oakhill J.S., Steinberg G.R. Adipose tissue as an endocrine organ. Mol. Cell. Endocrinol. 2010;316:129–139. doi: 10.1016/j.mce.2009.08.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mce.2009.08.018</ArticleId><ArticleId IdType="pubmed">19723556</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkowski J.M., Stern J.H., Scherer P.E. The cell biology of fat expansion. J. Cell Biol. 2015;208:501–512. doi: 10.1083/jcb.201409063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201409063</ArticleId><ArticleId IdType="pmc">PMC4347644</ArticleId><ArticleId IdType="pubmed">25733711</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens S.L. Fat-Soluble Vitamins. Nurs. Clin. N. Am. 2021;56:33–45. doi: 10.1016/j.cnur.2020.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cnur.2020.10.003</ArticleId><ArticleId IdType="pubmed">33549284</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfieri A., Imperlini E., Nigro E., Vitucci D., Orrù S., Daniele A., Buono P., Mancini A. Effects of Plant Oil Interesterified Triacylglycerols on Lipemia and Human Health. Int. J. Mol. Sci. 2017;19:104. doi: 10.3390/ijms19010104.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19010104</ArticleId><ArticleId IdType="pmc">PMC5796054</ArticleId><ArticleId IdType="pubmed">29301208</ArticleId></ArticleIdList></Reference><Reference><Citation>Ander B.P., Dupasquier C.M., Prociuk M.A., Pierce G.N.J.E., Cardiology C. Polyunsaturated fatty acids and their effects on cardiovascular disease. Exp. Clin. Cardiol. 2003;8:164–172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2719153</ArticleId><ArticleId IdType="pubmed">19649216</ArticleId></ArticleIdList></Reference><Reference><Citation>Orsavova J., Misurcova L., Ambrozova J.V., Vicha R., Mlcek J. Fatty Acids Composition of Vegetable Oils and Its Contribution to Dietary Energy Intake and Dependence of Cardiovascular Mortality on Dietary Intake of Fatty Acids. Int. J. Mol. Sci. 2015;16:12871–12890. doi: 10.3390/ijms160612871.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms160612871</ArticleId><ArticleId IdType="pmc">PMC4490476</ArticleId><ArticleId IdType="pubmed">26057750</ArticleId></ArticleIdList></Reference><Reference><Citation>Paton C.M., Ntambi J.M. Metabolism. Biochemical and physiological function of stearoyl-CoA desaturase. Am. J. Physiol. Endocrinol. Metab. 2009;297:E28–E37. doi: 10.1152/ajpendo.90897.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.90897.2008</ArticleId><ArticleId IdType="pmc">PMC2711665</ArticleId><ArticleId IdType="pubmed">19066317</ArticleId></ArticleIdList></Reference><Reference><Citation>Ros E. Dietary cis-monounsaturated fatty acids and metabolic control in type 2 diabetes23. Am. J. Clin. Nutr. 2003;78:617S–625S. doi: 10.1093/ajcn/78.3.617S.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/78.3.617S</ArticleId><ArticleId IdType="pubmed">12936956</ArticleId></ArticleIdList></Reference><Reference><Citation>Kris-Etherton P.M. Monounsaturated fatty acids and risk of cardiovascular disease. Circulation. 1999;100:1253–1258. doi: 10.1161/01.CIR.100.11.1253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.100.11.1253</ArticleId><ArticleId IdType="pubmed">10484550</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer B.J., Mann N.J., Lewis J.L., Milligan G.C., Sinclair A.J., Howe P.R. Dietary intakes and food sources of omega-6 and omega-3 polyunsaturated fatty acids. Lipids. 2003;38:391–398. doi: 10.1007/s11745-003-1074-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11745-003-1074-0</ArticleId><ArticleId IdType="pubmed">12848284</ArticleId></ArticleIdList></Reference><Reference><Citation>Panda C., Varadharaj S., Voruganti V.S. PUFA, genotypes and risk for cardiovascular disease. Prostaglandins Leukot. Essent. Fat. Acids. 2022;176:102377. doi: 10.1016/j.plefa.2021.102377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.plefa.2021.102377</ArticleId><ArticleId IdType="pubmed">34915303</ArticleId></ArticleIdList></Reference><Reference><Citation>Venegas-Calerón M., Sayanova O., Napier J.A. An alternative to fish oils: Metabolic engineering of oil-seed crops to produce omega-3 long chain polyunsaturated fatty acids. Prog. Lipid Res. 2010;49:108–119. doi: 10.1016/j.plipres.2009.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.plipres.2009.10.001</ArticleId><ArticleId IdType="pubmed">19857520</ArticleId></ArticleIdList></Reference><Reference><Citation>Alle E.E., Bartlett D.H. Structure and regulation of the omega-3 polyunsaturated fatty acid synthase genes from the deep-sea bacterium photobacterium profundum strain. Microbiology. 2002;148:1903–1913. doi: 10.1099/00221287-148-6-1903.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/00221287-148-6-1903</ArticleId><ArticleId IdType="pubmed">12055309</ArticleId></ArticleIdList></Reference><Reference><Citation>Abedi E., Sahari M.A. Long-chain polyunsaturated fatty acid sources and evaluation of their nutritional and functional properties. Food Sci. Nutr. 2014;5:443–463. doi: 10.1002/fsn3.121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/fsn3.121</ArticleId><ArticleId IdType="pmc">PMC4237475</ArticleId><ArticleId IdType="pubmed">25473503</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh D.Y., Talukdar S., Bae E.J., Imamura T., Morinaga H., Fan W., Li P., Lu W.J., Watkins S.M., Olefsky J.M. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell. 2010;142:687–698. doi: 10.1016/j.cell.2010.07.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.07.041</ArticleId><ArticleId IdType="pmc">PMC2956412</ArticleId><ArticleId IdType="pubmed">20813258</ArticleId></ArticleIdList></Reference><Reference><Citation>Heshmati J., Morvaridzadeh M., Maroufizadeh S., Akbari A., Yavari M., Amirinejad A., Maleki-Hajiagha A., Sepidarkish M. Omega-3 fatty acids supplementation and oxidative stress parameters: A systematic review and meta-analysis of clinical trials. Pharmacol. Res. 2019;149:104462. doi: 10.1016/j.phrs.2019.104462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2019.104462</ArticleId><ArticleId IdType="pubmed">31563611</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobryniewski J., Szajda S.D., Waszkiewicz N., Zwierz K. Biology of essential fatty acids (EFA) Przeglad Lekarski. 2007;64:91–99.</Citation><ArticleIdList><ArticleId IdType="pubmed">17892040</ArticleId></ArticleIdList></Reference><Reference><Citation>Innes J.K., Calder P.C. Omega-6 fatty acids and inflammation. Prostaglandins Leukot. Essent. Fat. Acids. 2018;132:41–48. doi: 10.1016/j.plefa.2018.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.plefa.2018.03.004</ArticleId><ArticleId IdType="pubmed">29610056</ArticleId></ArticleIdList></Reference><Reference><Citation>Barceló-Coblijn G., Murphy E.J. Alpha-linolenic acid and its conversion to longer chain n−3 fatty acids: Benefits for human health and a role in maintaining tissue n−3 fatty acid levels. Prog. Lipid Res. 2009;48:355–374. doi: 10.1016/j.plipres.2009.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.plipres.2009.07.002</ArticleId><ArticleId IdType="pubmed">19619583</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren J., Chung S.H. Anti-inflammatory Effect of α-Linolenic Acid and Its Mode of Action through the Inhibition of Nitric Oxide Production and Inducible Nitric Oxide Synthase Gene Expression via NF-κB and Mitogen-Activated Protein Kinase Pathways. J. Agric. Food Chem. 2007;55:5073–5080. doi: 10.1021/jf0702693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jf0702693</ArticleId><ArticleId IdType="pubmed">17542608</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanson D., Block R., Mousa S.A. Omega-3 fatty acids EPA and DHA: Health benefits throughout life. Adv. Nutr. 2012;3:1–7. doi: 10.3945/an.111.000893.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/an.111.000893</ArticleId><ArticleId IdType="pmc">PMC3262608</ArticleId><ArticleId IdType="pubmed">22332096</ArticleId></ArticleIdList></Reference><Reference><Citation>Whelan J., Fritsche K. Linoleic Acid. Adv. Nutr. 2013;4:311–312. doi: 10.3945/an.113.003772.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/an.113.003772</ArticleId><ArticleId IdType="pmc">PMC3650500</ArticleId><ArticleId IdType="pubmed">23674797</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuehl Jr F.A., Egan R.W. Prostaglandins, arachidonic acid, and inflammation. Science. 1980;210:978–984. doi: 10.1126/science.6254151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.6254151</ArticleId><ArticleId IdType="pubmed">6254151</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenna J.T., Salem N., Jr., Sinclair A.J., Cunnane S.C. α-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot. Essent. Fat. Acids. 2009;80:85–91. doi: 10.1016/j.plefa.2009.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.plefa.2009.01.004</ArticleId><ArticleId IdType="pubmed">19269799</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabian C., Kimler B., Hursting S. Omega-3 fatty acids for breast cancer prevention and survivorship. Breast Cancer Res. BCR. 2015;17:62. doi: 10.1186/s13058-015-0571-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13058-015-0571-6</ArticleId><ArticleId IdType="pmc">PMC4418048</ArticleId><ArticleId IdType="pubmed">25936773</ArticleId></ArticleIdList></Reference><Reference><Citation>Youdim K.A., Martin A., Joseph J.A. Essential fatty acids and the brain: Possible health implications. Int. J. Dev. Neurosci. 2000;18:383–399. doi: 10.1016/S0736-5748(00)00013-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0736-5748(00)00013-7</ArticleId><ArticleId IdType="pubmed">10817922</ArticleId></ArticleIdList></Reference><Reference><Citation>Calder P.C. Do Endogenously Produced and Dietary ω-3 Fatty Acids Act Differently? Function. 2023;4:zqad009. doi: 10.1093/function/zqad009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/function/zqad009</ArticleId><ArticleId IdType="pmc">PMC10165544</ArticleId><ArticleId IdType="pubmed">37168494</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon Y.A., Horton J.D. Identification of two mammalian reductases involved in the two-carbon fatty acyl elongation cascade. J. Biol. Chem. 2003;278:7335–7343. doi: 10.1074/jbc.M211684200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M211684200</ArticleId><ArticleId IdType="pubmed">12482854</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheppe A.E.F., Edelmann M.J. Roles of Eicosanoids in Regulating Inflammation and Neutrophil Migration as an Innate Host Response to Bacterial Infections. Infect. Immun. 2021;89:e0009521. doi: 10.1128/IAI.00095-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.00095-21</ArticleId><ArticleId IdType="pmc">PMC8281227</ArticleId><ArticleId IdType="pubmed">34031130</ArticleId></ArticleIdList></Reference><Reference><Citation>Calder P.C. Omega-3 fatty acids and inflammatory processes. Nutrients. 2010;2:355–374. doi: 10.3390/nu2030355.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu2030355</ArticleId><ArticleId IdType="pmc">PMC3257651</ArticleId><ArticleId IdType="pubmed">22254027</ArticleId></ArticleIdList></Reference><Reference><Citation>Djuricic I., Calder P.C. Beneficial Outcomes of Omega-6 and Omega-3 Polyunsaturated Fatty Acids on Human Health: An Update for 2021. Nutrients. 2021;13:2421. doi: 10.3390/nu13072421.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13072421</ArticleId><ArticleId IdType="pmc">PMC8308533</ArticleId><ArticleId IdType="pubmed">34371930</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson R.A., Muhlhausler B., Makrides M. Conversion of linoleic acid and alpha-linolenic acid to long-chain polyunsaturated fatty acids (LCPUFAs), with a focus on pregnancy, lactation and the first 2 years of life. Matern. Child. Nutr. 2011;7((Suppl. S2)):17–26. doi: 10.1111/j.1740-8709.2011.00299.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1740-8709.2011.00299.x</ArticleId><ArticleId IdType="pmc">PMC6860743</ArticleId><ArticleId IdType="pubmed">21366864</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns-Whitmore B., Froyen E., Heskey C., Parker T., San Pablo G. Alpha-Linolenic and Linoleic Fatty Acids in the Vegan Diet: Do They Require Dietary Reference Intake/Adequate Intake Special Consideration? Nutrients. 2019;11:2365. doi: 10.3390/nu11102365.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11102365</ArticleId><ArticleId IdType="pmc">PMC6835948</ArticleId><ArticleId IdType="pubmed">31590264</ArticleId></ArticleIdList></Reference><Reference><Citation>Murff H.J., Edwards T.L. Endogenous Production of Long-Chain Polyunsaturated Fatty Acids and Metabolic Disease Risk. Curr. Cardiovasc. Risk Rep. 2014;8:418. doi: 10.1007/s12170-014-0418-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12170-014-0418-1</ArticleId><ArticleId IdType="pmc">PMC4574498</ArticleId><ArticleId IdType="pubmed">26392837</ArticleId></ArticleIdList></Reference><Reference><Citation>Emken E.A., Adlof R.O., Gulley R.M. Dietary linoleic acid influences desaturation and acylation of deuterium-labeled linoleic and linolenic acids in young adult males. Biochim. Biophys. Acta (BBA) Lipids Lipid Metab. 1994;1213:277–288. doi: 10.1016/0005-2760(94)00054-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0005-2760(94)00054-9</ArticleId><ArticleId IdType="pubmed">7914092</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowak J.Z. Anti-inflammatory pro-resolving derivatives of omega-3 and omega-6 polyunsaturated fatty acids. Postep. Hig. I Med. Dosw. (Online) 2010;64:115–132.</Citation><ArticleIdList><ArticleId IdType="pubmed">20354260</ArticleId></ArticleIdList></Reference><Reference><Citation>Sansbury B.E., Spite M. Resolution of Acute Inflammation and the Role of Resolvins in Immunity, Thrombosis, and Vascular Biology. Circ. Res. 2016;119:113–130. doi: 10.1161/CIRCRESAHA.116.307308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.116.307308</ArticleId><ArticleId IdType="pmc">PMC5260827</ArticleId><ArticleId IdType="pubmed">27340271</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugimoto M.A., Sousa L.P., Pinho V., Perretti M., Teixeira M.M. Resolution of Inflammation: What Controls Its Onset? Front. Immunol. 2016;7:160. doi: 10.3389/fimmu.2016.00160.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2016.00160</ArticleId><ArticleId IdType="pmc">PMC4845539</ArticleId><ArticleId IdType="pubmed">27199985</ArticleId></ArticleIdList></Reference><Reference><Citation>Serhan C.N., Gupta S.K., Perretti M., Godson C., Brennan E., Li Y., Soehnlein O., Shimizu T., Werz O., Chiurchiù V., et al. The Atlas of Inflammation Resolution (AIR) Mol. Asp. Med. 2020;74:100894. doi: 10.1016/j.mam.2020.100894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mam.2020.100894</ArticleId><ArticleId IdType="pmc">PMC7733955</ArticleId><ArticleId IdType="pubmed">32893032</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Deng H., Cui H., Fang J., Zuo Z., Deng J., Li Y., Wang X., Zhao L. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2018;9:7204–7218. doi: 10.18632/oncotarget.23208.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.23208</ArticleId><ArticleId IdType="pmc">PMC5805548</ArticleId><ArticleId IdType="pubmed">29467962</ArticleId></ArticleIdList></Reference><Reference><Citation>Lubrano V., Ndreu R., Balzan S. Classes of Lipid Mediators and Their Effects on Vascular Inflammation in Atherosclerosis. Int. J. Mol. Sci. 2023;24:1637. doi: 10.3390/ijms24021637.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24021637</ArticleId><ArticleId IdType="pmc">PMC9863938</ArticleId><ArticleId IdType="pubmed">36675152</ArticleId></ArticleIdList></Reference><Reference><Citation>Umamaheswaran S., Dasari S.K., Yang P., Lutgendorf S.K., Sood A.K. Stress, inflammation, and eicosanoids: An emerging perspective. Cancer Metastasis Rev. 2018;37:203–211. doi: 10.1007/s10555-018-9741-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10555-018-9741-1</ArticleId><ArticleId IdType="pmc">PMC6237279</ArticleId><ArticleId IdType="pubmed">29948328</ArticleId></ArticleIdList></Reference><Reference><Citation>Tithof P.K., Peters-Golden M., Ganey P.E. Distinct phospholipases A2 regulate the release of arachidonic acid for eicosanoid production and superoxide anion generation in neutrophils. J. Immunol. 1998;160:953–960. doi: 10.4049/jimmunol.160.2.953.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.160.2.953</ArticleId><ArticleId IdType="pubmed">9551934</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherwood E.R., Toliver-Kinsky T. Mechanisms of the inflammatory response. Best Pract. Res. Clin. Anaesthesiol. 2004;18:385–405. doi: 10.1016/j.bpa.2003.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpa.2003.12.002</ArticleId><ArticleId IdType="pubmed">15212335</ArticleId></ArticleIdList></Reference><Reference><Citation>Garavito R.M., DeWitt D.L. The cyclooxygenase isoforms: Structural insights into the conversion of arachidonic acid to prostaglandins. Biochim. Biophys. Acta (BBA) Mol. Cell Biol. Lipids. 1999;1441:278–287. doi: 10.1016/S1388-1981(99)00147-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1388-1981(99)00147-X</ArticleId><ArticleId IdType="pubmed">10570255</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Seibold S.A., Rieke C.J., Song I., Cukier R.I., Smith W.L. Prostaglandin endoperoxide H synthases: Peroxidase hydroperoxide specificity and cyclooxygenase activation. J. Biol. Chem. 2007;282:18233–18244. doi: 10.1074/jbc.M701235200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M701235200</ArticleId><ArticleId IdType="pubmed">17462992</ArticleId></ArticleIdList></Reference><Reference><Citation>Herschman H.R. Prostaglandin synthase 2. Biochim. Biophys. Acta (BBA) Lipids Lipid Metab. 1996;1299:125–140. doi: 10.1016/0005-2760(95)00194-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0005-2760(95)00194-8</ArticleId><ArticleId IdType="pubmed">8555245</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricciotti E., FitzGerald G.A. Prostaglandins and inflammation. Arterioscler. Thromb. Vasc. Biol. 2011;31:986–1000. doi: 10.1161/ATVBAHA.110.207449.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.110.207449</ArticleId><ArticleId IdType="pmc">PMC3081099</ArticleId><ArticleId IdType="pubmed">21508345</ArticleId></ArticleIdList></Reference><Reference><Citation>Seibert K., Zhang Y., Leahy K., Hauser S., Masferrer J., Perkins W., Lee L., Isakson P. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. Natl. Acad. Sci. USA. 1994;91:12013–12017. doi: 10.1073/pnas.91.25.12013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.91.25.12013</ArticleId><ArticleId IdType="pmc">PMC45366</ArticleId><ArticleId IdType="pubmed">7991575</ArticleId></ArticleIdList></Reference><Reference><Citation>Serhan C.N., Clish C.B., Brannon J., Colgan S.P., Chiang N., Gronert K. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J. Exp. Med. 2000;192:1197–1204. doi: 10.1084/jem.192.8.1197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.192.8.1197</ArticleId><ArticleId IdType="pmc">PMC2195872</ArticleId><ArticleId IdType="pubmed">11034610</ArticleId></ArticleIdList></Reference><Reference><Citation>Das U. Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules. Lipids Health Dis. 2008;7:37. doi: 10.1186/1476-511X-7-37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1476-511X-7-37</ArticleId><ArticleId IdType="pmc">PMC2576273</ArticleId><ArticleId IdType="pubmed">18922179</ArticleId></ArticleIdList></Reference><Reference><Citation>Serhan C.N., Chiang N., Van Dyke T.E. Resolving inflammation: Dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 2008;8:349–361. doi: 10.1038/nri2294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2294</ArticleId><ArticleId IdType="pmc">PMC2744593</ArticleId><ArticleId IdType="pubmed">18437155</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M., Yoshida M., Hong S., Tjonahen E., Glickman J.N., Petasis N.A., Blumberg R.S., Serhan C.N. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc. Natl. Acad. Sci. USA. 2005;102:7671–7676. doi: 10.1073/pnas.0409271102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0409271102</ArticleId><ArticleId IdType="pmc">PMC1103706</ArticleId><ArticleId IdType="pubmed">15890784</ArticleId></ArticleIdList></Reference><Reference><Citation>Julliard W.A., Myo Y.P.A., Perelas A., Jackson P.D., Thatcher T.H., Sime P.J. Specialized pro-resolving mediators as modulators of immune responses. Semin. Immunol. 2022;59:101605. doi: 10.1016/j.smim.2022.101605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2022.101605</ArticleId><ArticleId IdType="pmc">PMC9962762</ArticleId><ArticleId IdType="pubmed">35660338</ArticleId></ArticleIdList></Reference><Reference><Citation>Serhan C.N., Krishnamoorthy S., Recchiuti A., Chiang N. Novel anti-inflammatory--pro-resolving mediators and their receptors. Curr. Top. Med. Chem. 2011;11:629–647. doi: 10.2174/1568026611109060629.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568026611109060629</ArticleId><ArticleId IdType="pmc">PMC3094721</ArticleId><ArticleId IdType="pubmed">21261595</ArticleId></ArticleIdList></Reference><Reference><Citation>Hichami A., Datiche F., Ullah S., Liénard F., Chardigny J.M., Cattarelli M., Khan N.A. Olfactory discrimination ability and brain expression of c-fos, Gir and Glut1 mRNA are altered in n-3 fatty acid-depleted rats. Behav. Brain Res. 2007;184:1–10. doi: 10.1016/j.bbr.2007.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2007.06.010</ArticleId><ArticleId IdType="pubmed">17686536</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan L., Gu M.Q., Yang Z.Y., Xia J., Li P., Vasar E., Tian L., Song C. Endogenous n-3 PUFAs attenuated olfactory bulbectomy-induced behavioral and metabolomic abnormalities in Fat-1 mice. Brain Behav. Immun. 2021;96:143–153. doi: 10.1016/j.bbi.2021.05.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.05.024</ArticleId><ArticleId IdType="pubmed">34052364</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoury S., Gudziol V., Grégoire S., Cabaret S., Menzel S., Martine L., Mézière E., Soubeyre V., Thomas-Danguin T., Grosmaitre X., et al. Lipidomic profile of human nasal mucosa and associations with circulating fatty acids and olfactory deficiency. Sci. Rep. 2021;11:16771. doi: 10.1038/s41598-021-93817-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-93817-1</ArticleId><ArticleId IdType="pmc">PMC8373950</ArticleId><ArticleId IdType="pubmed">34408170</ArticleId></ArticleIdList></Reference><Reference><Citation>Greiner R.S., Moriguchi T., Slotnick B.M., Hutton A., Salem N. Olfactory discrimination deficits in n-3 fatty acid-deficient rats. Physiol. Behav. 2001;72:379–385. doi: 10.1016/S0031-9384(00)00437-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0031-9384(00)00437-6</ArticleId><ArticleId IdType="pubmed">11274681</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopinath B., Sue C.M., Flood V.M., Burlutsky G., Mitchell P. Dietary intakes of fats, fish and nuts and olfactory impairment in older adults. Br. J. Nutr. 2015;114:240–247. doi: 10.1017/S0007114515001257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0007114515001257</ArticleId><ArticleId IdType="pubmed">26079067</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan C.H., Rathor A., Krook K., Ma Y., Rotella M.R., Dodd R.L., Hwang P.H., Nayak J.V., Oyesiku N.M., DelGaudio J.M., et al. Effect of Omega-3 Supplementation in Patients With Smell Dysfunction Following Endoscopic Sellar and Parasellar Tumor Resection: A Multicenter Prospective Randomized Controlled Trial. Neurosurgery. 2020;87:E91–E98. doi: 10.1093/neuros/nyz559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/neuros/nyz559</ArticleId><ArticleId IdType="pmc">PMC7360874</ArticleId><ArticleId IdType="pubmed">31950156</ArticleId></ArticleIdList></Reference><Reference><Citation>Soubeyre V., Merle L., Jarriault D., Grégoire S., Bretillon L., Acar N., Grosmaitre X., Le Bon A.M. Dietary n-3 polyunsaturated fatty acid deficiency alters olfactory mucosa sensitivity in young mice but has no impact on olfactory behavior. Nutr. Neurosci. 2022;26:706–719. doi: 10.1080/1028415X.2022.2082642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1028415X.2022.2082642</ArticleId><ArticleId IdType="pubmed">35694841</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Bon A.M., Deprêtre N., Sibille E., Cabaret S., Grégoire S., Soubeyre V., Masson E., Acar N., Bretillon L., Grosmaitre X., et al. Comprehensive study of rodent olfactory tissue lipid composition. Prostaglandins Leukot. Essent. Fat. Acids. 2018;131:32–43. doi: 10.1016/j.plefa.2018.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.plefa.2018.03.008</ArticleId><ArticleId IdType="pubmed">29628048</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoury S., Soubeyre V., Cabaret S., Merle L., Grégoire S., Deprêtre N., Jarriault D., Grosmaitre X., Bretillon L., Berdeaux O., et al. Perinatal exposure to diets with different n-6:n-3 fatty acid ratios affects olfactory tissue fatty acid composition. Sci. Rep. 2020;10:10785. doi: 10.1038/s41598-020-67725-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-67725-9</ArticleId><ArticleId IdType="pmc">PMC7329853</ArticleId><ArticleId IdType="pubmed">32612195</ArticleId></ArticleIdList></Reference><Reference><Citation>Murthy V.N., De Camilli P. Cell biology of the presynaptic terminal. Annu. Rev. Neurosci. 2003;26:701–728. doi: 10.1146/annurev.neuro.26.041002.131445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.neuro.26.041002.131445</ArticleId><ArticleId IdType="pubmed">14527272</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustine G.J., Burns M.E., DeBello W.M., Hilfiker S., Morgan J.R., Schweizer F.E., Tokumaru H., Umayahara K. Proteins involved in synaptic vesicle trafficking. J. Physiol. 1999;520 Pt 1:33–41. doi: 10.1111/j.1469-7793.1999.00033.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-7793.1999.00033.x</ArticleId><ArticleId IdType="pmc">PMC2269560</ArticleId><ArticleId IdType="pubmed">10517798</ArticleId></ArticleIdList></Reference><Reference><Citation>Klopfenstein D.R., Vale R.D. The lipid binding pleckstrin homology domain in UNC-104 kinesin is necessary for synaptic vesicle transport in Caenorhabditis elegans. Mol. Biol. Cell. 2004;15:3729–3739. doi: 10.1091/mbc.e04-04-0326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e04-04-0326</ArticleId><ArticleId IdType="pmc">PMC491832</ArticleId><ArticleId IdType="pubmed">15155810</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmari S.E., Buchanan J., Smith S.J. Assembly of presynaptic active zones from cytoplasmic transport packets. Nat. Neurosci. 2000;3:445–451. doi: 10.1038/74814.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/74814</ArticleId><ArticleId IdType="pubmed">10769383</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannah M.J., Schmidt A.A., Huttner W.B. Synaptic vesicle biogenesis. Annu. Rev. Cell Dev. Biol. 1999;15:733–798. doi: 10.1146/annurev.cellbio.15.1.733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.cellbio.15.1.733</ArticleId><ArticleId IdType="pubmed">10611977</ArticleId></ArticleIdList></Reference><Reference><Citation>Liedtke W. Transient receptor potential vanilloid channels functioning in transduction of osmotic stimuli. J. Endocrinol. 2006;191:515–523. doi: 10.1677/joe.1.07000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1677/joe.1.07000</ArticleId><ArticleId IdType="pubmed">17170210</ArticleId></ArticleIdList></Reference><Reference><Citation>Sze J.Y. The TRPV Channel in C. elegans Serotonergic Neurons. In: Liedtke W.B., Heller S., editors. TRP Ion Channel Function in Sensory Transduction and Cellular Signaling Cascades. CRC Press/Taylor &amp; Francis; Boca Raton, FL, USA: 2007. Chapter 18.</Citation><ArticleIdList><ArticleId IdType="pubmed">21204486</ArticleId></ArticleIdList></Reference><Reference><Citation>Noelle D., Coburn C.M., Eastham J., Kistler A., Gallegos G., Bargmann C.I. The cyclic GMP-dependent protein kinase EGL-4 regulates olfactory adaptation in C. elegans. Neuron. 2002;36:1079–1089. doi: 10.1016/s0896-6273(02)01066-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0896-6273(02)01066-8</ArticleId><ArticleId IdType="pubmed">12495623</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaye J.A., Rose N.C., Goldsworthy B., Goga A., L’Etoile N.D. A 3′UTR pumilio-binding element directs translational activation in olfactory sensory neurons. Neuron. 2009;61:57–70. doi: 10.1016/j.neuron.2008.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2008.11.012</ArticleId><ArticleId IdType="pmc">PMC4274156</ArticleId><ArticleId IdType="pubmed">19146813</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., O’Halloran D., Kaye J., Juang B., Goga A., L’Etoile N. Nuclear entry of a cGMP-dependent kinase converts transient into long-lasting olfactory adaptation. Proc. Natl. Acad. Sci. 2010;107:6016–6021. doi: 10.1073/pnas.1000866107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1000866107</ArticleId><ArticleId IdType="pmc">PMC2851914</ArticleId><ArticleId IdType="pubmed">20220099</ArticleId></ArticleIdList></Reference><Reference><Citation>Borja-Magno A.I., Furuzawa-Carballeda J., Guevara-Cruz M., Arias C., Granados J., Bourges H., Tovar A.R., Sears B., Noriega L.G., Gómez F.E. Supplementation with EPA and DHA omega-3 fatty acids improves peripheral immune cell mitochondrial dysfunction and inflammation in subjects with obesity. J. Nutr. Biochem. 2023;120:109415. doi: 10.1016/j.jnutbio.2023.109415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2023.109415</ArticleId><ArticleId IdType="pubmed">37437746</ArticleId></ArticleIdList></Reference><Reference><Citation>Bou M., Torgersen J.S., Østbye T.-K.K., Ruyter B., Wang X., Škugor S., Kristiansen I.Ø., Todorčević M. DHA modulates immune response and mitochondrial function of atlantic salmon adipocytes after LPS Treatment. Int. J. Mol. Sci. 2020;21:4101. doi: 10.3390/ijms21114101.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21114101</ArticleId><ArticleId IdType="pmc">PMC7312884</ArticleId><ArticleId IdType="pubmed">32521827</ArticleId></ArticleIdList></Reference><Reference><Citation>Campanari D.D., Cipriano U.G., Fraga-Silva T.F.d.C., Ramalho L.N.Z., Ovidio P.P., Jordão Júnior A.A., Bonato V.L.D., Ferriolli E. Effect of Dietary Supplementation with Omega-3 fatty acid on the generation of regulatory T lymphocytes and on antioxidant parameters and markers of oxidative stress in the liver tissue of IL−10 knockout mice. Nutrients. 2024;5:634. doi: 10.3390/nu16050634.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu16050634</ArticleId><ArticleId IdType="pmc">PMC10934328</ArticleId><ArticleId IdType="pubmed">38474762</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen J., Satyanarayanan S.K., Li A., Yan L., Zhao Z., Yuan Q., Su K.-P., Su H. Unraveling the impact of Omega-3 polyunsaturated fatty acids on blood-brain barrier (BBB) integrity and glymphatic function. Brain Behav. Immun. 2024;115:335–355. doi: 10.1016/j.bbi.2023.10.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2023.10.018</ArticleId><ArticleId IdType="pubmed">37914102</ArticleId></ArticleIdList></Reference><Reference><Citation>Joffre C., Rey C., Layé S. N-3 Polyunsaturated Fatty Acids and the Resolution of Neuroinflammation. Front. Pharmacol. 2019;10:1022. doi: 10.3389/fphar.2019.01022.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2019.01022</ArticleId><ArticleId IdType="pmc">PMC6755339</ArticleId><ArticleId IdType="pubmed">31607902</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapoor D., Verma N., Gupta N., Goyal A. Post Viral Olfactory Dysfunction After SARS-CoV-2 Infection: Anticipated Post-pandemic Clinical Challenge. Indian J. Otolaryngol. Head. Neck Surg. 2022;74:4571–4578. doi: 10.1007/s12070-021-02730-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12070-021-02730-6</ArticleId><ArticleId IdType="pmc">PMC8260324</ArticleId><ArticleId IdType="pubmed">34249668</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Anwar M.W., Mohamed S.M., Sweed A.H. Smell disorders associated with COVID-19 infection. Egypt. J. Otolaryngol. 2021;37:37. doi: 10.1186/s43163-021-00095-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43163-021-00095-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghadirzadeh E., Davoodi L., Khazaei F., Taheri A. Spontaneous recovery of anosmia after 2.5 years in a young COVID-19 patient. Eur. Clin. Respir. J. 2023;10:2178598. doi: 10.1080/20018525.2023.2178598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/20018525.2023.2178598</ArticleId><ArticleId IdType="pmc">PMC9930803</ArticleId><ArticleId IdType="pubmed">36815941</ArticleId></ArticleIdList></Reference><Reference><Citation>Fodoulian L., Tuberosa J., Rossier D., Boillat M., Kan C., Pauli V., Egervari K., Lobrinus J.A., Landis B.N., Carleton A., et al. SARS-CoV-2 Receptors and Entry Genes Are Expressed in the Human Olfactory Neuroepithelium and Brain. iScience. 2020;23:101839. doi: 10.1016/j.isci.2020.101839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101839</ArticleId><ArticleId IdType="pmc">PMC7685946</ArticleId><ArticleId IdType="pubmed">33251489</ArticleId></ArticleIdList></Reference><Reference><Citation>Aragão M., Leal M.C., Cartaxo Filho O.Q., Fonseca T.M., Valença M.M. Anosmia in COVID-19 Associated with Injury to the Olfactory Bulbs Evident on MRI. AJNR Am. J. Neuroradiol. 2020;41:1703–1706. doi: 10.3174/ajnr.A6675.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A6675</ArticleId><ArticleId IdType="pmc">PMC7583088</ArticleId><ArticleId IdType="pubmed">32586960</ArticleId></ArticleIdList></Reference><Reference><Citation>Parma V., Ohla K., Veldhuizen M.G., Niv M.Y., Kelly C.E., Bakke A.J., Cooper K.W., Bouysset C., Pirastu N., Dibattista M., et al. More Than Smell-COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis. Chem. Senses. 2020;45:609–622. doi: 10.1093/chemse/bjaa041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/chemse/bjaa041</ArticleId><ArticleId IdType="pmc">PMC7337664</ArticleId><ArticleId IdType="pubmed">32564071</ArticleId></ArticleIdList></Reference><Reference><Citation>Neta F.I., Fernandes A.C.L., Vale A.J.M., Pinheiro F.I., Cobucci R.N., Azevedo E.P., Guzen F.P. Pathophysiology and possible treatments for olfactory-gustatory disorders in patients affected by COVID-19. Curr. Res. Pharmacol. Drug Discov. 2021;2:100035. doi: 10.1016/j.crphar.2021.100035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.crphar.2021.100035</ArticleId><ArticleId IdType="pmc">PMC8178068</ArticleId><ArticleId IdType="pubmed">34870148</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu L.W., Quek S.-Y., Lu S.-P., Chen J.-H. Potential benefits of Omega-3 polyunsaturated fatty acids (N3PUFAs) on cardiovascular health associated with COVID-19: An update for 2023. Metabolites. 2023;13:630. doi: 10.3390/metabo13050630.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo13050630</ArticleId><ArticleId IdType="pmc">PMC10222821</ArticleId><ArticleId IdType="pubmed">37233671</ArticleId></ArticleIdList></Reference><Reference><Citation>Doaei S., Gholami S., Rastgoo S., Gholamalizadeh M., Bourbour F., Bagheri S.E., Samipoor F., Akbari M.E., Shadnoush M., Ghorat F., et al. The effect of omega-3 fatty acid supplementation on clinical and biochemical parameters of critically ill patients with COVID-19: A randomized clinical trial. J. Transl. Med. 2021;19:128. doi: 10.1186/s12967-021-02795-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-02795-5</ArticleId><ArticleId IdType="pmc">PMC8006115</ArticleId><ArticleId IdType="pubmed">33781275</ArticleId></ArticleIdList></Reference><Reference><Citation>Baral P.K., Amin M.T., Rashid M.M.O., Hossain M.S. Assessment of Polyunsaturated Fatty Acids on COVID-19-Associated Risk Reduction. Rev. Bras. Farmacogn. 2022;32:50–64. doi: 10.1007/s43450-021-00213-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s43450-021-00213-x</ArticleId><ArticleId IdType="pmc">PMC8638948</ArticleId><ArticleId IdType="pubmed">34876760</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampova B., Doskocil I., Kourimska L., Kopec A. N-3 polyunsaturated fatty acids may affect the course of COVID-19. Front. Immunol. 2022;13:957518. doi: 10.3389/fimmu.2022.957518.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.957518</ArticleId><ArticleId IdType="pmc">PMC9551352</ArticleId><ArticleId IdType="pubmed">36238306</ArticleId></ArticleIdList></Reference><Reference><Citation>Velotti F., Costantini L., Merendino N. Omega-3 Polyunsaturated Fatty Acids (n-3 PUFAs) for Immunomodulation in COVID-19 Related Acute Respiratory Distress Syndrome (ARDS) J. Clin. Medien. 2022;12:304. doi: 10.3390/jcm12010304.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12010304</ArticleId><ArticleId IdType="pmc">PMC9820910</ArticleId><ArticleId IdType="pubmed">36615103</ArticleId></ArticleIdList></Reference><Reference><Citation>Husson M.O., Ley D., Portal C., Gottrand M., Hueso T., Desseyn J.L., Gottrand F. Modulation of host defence against bacterial and viral infections by omega-3 polyunsaturated fatty acids. J. Infect. 2016;73:523–535. doi: 10.1016/j.jinf.2016.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2016.10.001</ArticleId><ArticleId IdType="pubmed">27746159</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai Y. Role of omega-3 PUFA-derived mediators, the protectins, in influenza virus infection. Biochim. Biophys. Acta. 2015;1851:496–502. doi: 10.1016/j.bbalip.2015.01.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbalip.2015.01.006</ArticleId><ArticleId IdType="pubmed">25617737</ArticleId></ArticleIdList></Reference><Reference><Citation>Goc A., Niedzwiecki A., Rath M. Polyunsaturated ω-3 fatty acids inhibit ACE2-controlled SARS-CoV-2 binding and cellular entry. Sci. Rep. 2021;11:5207. doi: 10.1038/s41598-021-84850-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-84850-1</ArticleId><ArticleId IdType="pmc">PMC7933164</ArticleId><ArticleId IdType="pubmed">33664446</ArticleId></ArticleIdList></Reference><Reference><Citation>Weill P., Plissonneau C., Legrand P., Rioux V., Thibault R. May omega-3 fatty acid dietary supplementation help reduce severe complications in Covid-19 patients? Biochimie. 2020;179:275–280. doi: 10.1016/j.biochi.2020.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2020.09.003</ArticleId><ArticleId IdType="pmc">PMC7481803</ArticleId><ArticleId IdType="pubmed">32920170</ArticleId></ArticleIdList></Reference><Reference><Citation>Basil M.C., Levy B.D. Specialized pro-resolving mediators: Endogenous regulators of infection and inflammation. Nat. Rev. Immunol. 2016;16:51–67. doi: 10.1038/nri.2015.4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2015.4</ArticleId><ArticleId IdType="pmc">PMC5242505</ArticleId><ArticleId IdType="pubmed">26688348</ArticleId></ArticleIdList></Reference><Reference><Citation>Serhan C.N., Arita M., Hong S., Gotlinger K. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids. 2004;39:1125–1132. doi: 10.1007/s11745-004-1339-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11745-004-1339-7</ArticleId><ArticleId IdType="pubmed">15726828</ArticleId></ArticleIdList></Reference><Reference><Citation>Calder P.C. Omega-3 polyunsaturated fatty acids and inflammatory processes: Nutrition or pharmacology? Br. J. Clin. Pharmacol. 2013;75:645–662. doi: 10.1111/j.1365-2125.2012.04374.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2125.2012.04374.x</ArticleId><ArticleId IdType="pmc">PMC3575932</ArticleId><ArticleId IdType="pubmed">22765297</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega-Gómez A., Perretti M., Soehnlein O. Resolution of inflammation: An integrated view. EMBO Mol. Med. 2013;5:661–674. doi: 10.1002/emmm.201202382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emmm.201202382</ArticleId><ArticleId IdType="pmc">PMC3662311</ArticleId><ArticleId IdType="pubmed">23592557</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnardottir H., Pawelzik S.C., Öhlund Wistbacka U., Artiach G., Hofmann R., Reinholdsson I., Braunschweig F., Tornvall P., Religa D., Bäck M. Stimulating the Resolution of Inflammation Through Omega-3 Polyunsaturated Fatty Acids in COVID-19: Rationale for the COVID-Omega-F Trial. Front. Physiol. 2020;11:624657. doi: 10.3389/fphys.2020.624657.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.624657</ArticleId><ArticleId IdType="pmc">PMC7830247</ArticleId><ArticleId IdType="pubmed">33505321</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasmeen N., Selvaraj H., Lakhawat S.S., Datta M., Sharma P.K., Jain A., Khanna R., Srinivasan J., Kumar V. Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators. Biochem. Pharmacol. 2023;209:115437. doi: 10.1016/j.bcp.2023.115437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2023.115437</ArticleId><ArticleId IdType="pmc">PMC9884647</ArticleId><ArticleId IdType="pubmed">36731803</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannenberg G., Serhan C.N. Specialized pro-resolving lipid mediators in the inflammatory response: An update. Biochim. Biophys. Acta. 2010;1801:1260–1273. doi: 10.1016/j.bbalip.2010.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbalip.2010.08.002</ArticleId><ArticleId IdType="pmc">PMC2994245</ArticleId><ArticleId IdType="pubmed">20708099</ArticleId></ArticleIdList></Reference><Reference><Citation>Serhan C.N., Chiang N. Resolvins and cysteinyl-containing pro-resolving mediators activate resolution of infectious inflammation and tissue regeneration. Prostaglandins Other Lipid Mediat. 2023;166:106718. doi: 10.1016/j.prostaglandins.2023.106718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prostaglandins.2023.106718</ArticleId><ArticleId IdType="pmc">PMC10175197</ArticleId><ArticleId IdType="pubmed">36813255</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>